ASTRAZENECA DeAL gives cellectis take -off strip of $ 264 million News ad
Cellectis today $ 1.44 +0.06 (+4.35%) As of 04.22.2025 21:00 52-week range $ 1.10 ▼ $ 3.38 Value is valuable $ 7.00 Cellecta SA NASDAQ: Clls Is the clinical stage of a biotechnological company aimed at developing “ready -made” cancer immunotherapy using the use Genes editing technology. Following significant strategic investments in Astrazeneca shareholder capital … Read more
